Multiple myeloma trials in Germany
8 of 64 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleExercise Phenotyping Prior to Chemotherapy in Newly Diagnosed Multiple Myeloma (MM-Exercise)
- Where
- Munich
- Age
- 18 years to 99 years
- People
- 80
- Run by
- Technical University of Munich
See details and how to joinNCT07851493 - No phaseTaking peopleA Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
- Where
- Chemnitz, Dresden, Hamburg, Hanover, Heidelberg, Nuremberg, Würzburg
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Janssen-Cilag Ltd.
See details and how to joinNCT06285318 - No phaseTaking peopleMyeloma Registry Platform (MYRIAM)
- Where
- Multiple Sites
- Age
- 18 years and over
- People
- 2,200
- Run by
- iOMEDICO AG
See details and how to joinNCT03308474 - No phaseTaking peopleA Non-interventional Study of Melphalan Flufenamide (Melflufen) (Pepaxti®) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma (R/RMM)
- Where
- Freiburg im Breisgau
- Age
- 18 years and over
- People
- 50
- Run by
- iOMEDICO AG
See details and how to joinNCT07559799 - No phaseTaking peopleReal-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
- Where
- Berlin
- Age
- 18 years and over
- People
- 75 worldwide
- Run by
- Takeda
See details and how to joinNCT05879757 - No phaseTaking peopleTransgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Where
- Essen
- People
- 50 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06357754 - No phaseTaking peopleGMMG Multiple Myeloma Registry
- Where
- Berlin, Bielefeld, Bochum, Bonn, Chemnitz, Cologne, Darmstadt, Düsseldorf, Erlangen, Essen, Frankfurt am Main, Giessen, Hagen, Hamburg, Heidelberg, Heilbronn, Homburg, Kaiserslautern, Koblenz, Lebach, Mainz, Mannheim, Marburg, Mönchengladbach, Regensburg, Schwäbisch Hall, Siegburg, Speyer, Trier, Tübingen
- Age
- 18 years and over
- People
- 999
- Run by
- Prof. Dr. Hartmut Goldschmidt
See details and how to joinNCT07111884 - No phaseTaking peopleDeveloping a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project
- Where
- Berlin, Garmisch-Partenkirchen
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Medical University Innsbruck
See details and how to joinNCT06821880